Literature DB >> 24511380

Evolution of intratumoral phenotypic heterogeneity: the role of trait inheritance.

Jill Gallaher1, Alexander R A Anderson1.   

Abstract

A tumour is a heterogeneous population of cells that competes for limited resources. In the clinic, we typically probe the tumour by biopsy, and then characterize it by the dominant genetic clone. But genotypes are only the first link in the chain of hierarchical events that leads to a specific cell phenotype. The relationship between genotype and phenotype is not simple, and the so-called genotype to phenotype map is poorly understood. Many genotypes can produce the same phenotype, so genetic heterogeneity may not translate directly to phenotypic heterogeneity. We therefore choose to focus on the functional endpoint, the phenotype as defined by a collection of cellular traits (e.g. proliferative and migratory ability). Here, we will examine how phenotypic heterogeneity evolves in space and time and how the way in which phenotypes are inherited will drive this evolution. A tumour can be thought of as an ecosystem, which critically means that we cannot just consider it as a collection of mutated cells but more as a complex system of many interacting cellular and microenvironmental elements. At its simplest, a growing tumour with increased proliferation capacity must compete for space as a limited resource. Hypercellularity leads to a contact-inhibited core with a competitive proliferating rim. Evolution and selection occurs, and an individual cell's capacity to survive and propagate is determined by its combination of traits and interaction with the environment. With heterogeneity in phenotypes, the clone that will dominate is not always obvious as there are both local interactions and global pressures. Several combinations of phenotypes can coexist, changing the fitness of the whole. To understand some aspects of heterogeneity in a growing tumour, we build an off-lattice agent-based model consisting of individual cells with assigned trait values for proliferation and migration rates. We represent heterogeneity in these traits with frequency distributions and combinations of traits with density maps. How the distributions change over time is dependent on how traits are passed on to progeny cells, which is our main enquiry. We bypass the translation of genetics to behaviour by focusing on the functional end result of inheritance of the phenotype combined with the environmental influence of limited space.

Entities:  

Keywords:  evolution; heterogeneity; phenotypic inheritance

Year:  2013        PMID: 24511380      PMCID: PMC3915835          DOI: 10.1098/rsfs.2013.0016

Source DB:  PubMed          Journal:  Interface Focus        ISSN: 2042-8898            Impact factor:   3.906


  30 in total

Review 1.  Timescales of genetic and epigenetic inheritance.

Authors:  Oliver J Rando; Kevin J Verstrepen
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

2.  Estimating clonal heterogeneity and interexperiment variability with the bifurcating autoregressive model for cell lineage data.

Authors:  R G Staudte; R M Huggins; J Zhang; D E Axelrod; M Kimmel
Journal:  Math Biosci       Date:  1997-07-15       Impact factor: 2.144

Review 3.  Beyond genotype to phenotype: why the phenotype of an individual cannot always be predicted from their genome sequence and the environment that they experience.

Authors:  Alejandro Burga; Ben Lehner
Journal:  FEBS J       Date:  2012-09-27       Impact factor: 5.542

4.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

Authors:  Andrea Sottoriva; Inmaculada Spiteri; Sara G M Piccirillo; Anestis Touloumis; V Peter Collins; John C Marioni; Christina Curtis; Colin Watts; Simon Tavaré
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-14       Impact factor: 11.205

Review 5.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

Review 6.  Clonal evolution in cancer.

Authors:  Mel Greaves; Carlo C Maley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

7.  Nest expansion assay: a cancer systems biology approach to in vitro invasion measurements.

Authors:  Yoonseok Kam; Audrey Karperien; Brandy Weidow; Lourdes Estrada; Alexander R Anderson; Vito Quaranta
Journal:  BMC Res Notes       Date:  2009-07-13

8.  Microenvironmental independence associated with tumor progression.

Authors:  Alexander R A Anderson; Mohamed Hassanein; Kevin M Branch; Jenny Lu; Nichole A Lobdell; Julie Maier; David Basanta; Brandy Weidow; Archana Narasanna; Carlos L Arteaga; Albert B Reynolds; Vito Quaranta; Lourdes Estrada; Alissa M Weaver
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

Review 9.  Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours.

Authors:  Amy Brock; Hannah Chang; Sui Huang
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

Review 10.  Intratumor heterogeneity: evolution through space and time.

Authors:  Charles Swanton
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

View more
  16 in total

Review 1.  Ecological paradigms to understand the dynamics of metastasis.

Authors:  Sarah R Amend; Sounak Roy; Joel S Brown; Kenneth J Pienta
Journal:  Cancer Lett       Date:  2015-10-10       Impact factor: 8.679

Review 2.  A population genetics perspective on the determinants of intra-tumor heterogeneity.

Authors:  Zheng Hu; Ruping Sun; Christina Curtis
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-03-06       Impact factor: 10.680

Review 3.  The mathematics of cancer: integrating quantitative models.

Authors:  Philipp M Altrock; Lin L Liu; Franziska Michor
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

4.  Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies.

Authors:  Jill A Gallaher; Pedro M Enriquez-Navas; Kimberly A Luddy; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2018-01-30       Impact factor: 12.701

5.  Modeling Tumor Evolutionary Dynamics to Predict Clinical Outcomes for Patients with Metastatic Colorectal Cancer: A Retrospective Analysis.

Authors:  Jiawei Zhou; Yutong Liu; Yubo Zhang; Quefeng Li; Yanguang Cao
Journal:  Cancer Res       Date:  2019-11-01       Impact factor: 12.701

Review 6.  Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.

Authors:  Thomas E Yankeelov; Gary An; Oliver Saut; E Georg Luebeck; Aleksander S Popel; Benjamin Ribba; Paolo Vicini; Xiaobo Zhou; Jared A Weis; Kaiming Ye; Guy M Genin
Journal:  Ann Biomed Eng       Date:  2016-07-06       Impact factor: 3.934

7.  Biomarkers from in vivo molecular imaging of breast cancer: pretreatment 18F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapy.

Authors:  Francesca Gallivanone; Marta Maria Panzeri; Carla Canevari; Claudio Losio; Luigi Gianolli; Francesco De Cobelli; Isabella Castiglioni
Journal:  MAGMA       Date:  2017-02-28       Impact factor: 2.310

8.  Learning differential equation models from stochastic agent-based model simulations.

Authors:  John T Nardini; Ruth E Baker; Matthew J Simpson; Kevin B Flores
Journal:  J R Soc Interface       Date:  2021-03-17       Impact factor: 4.118

9.  A Mathematical Study of the Influence of Hypoxia and Acidity on the Evolutionary Dynamics of Cancer.

Authors:  Giada Fiandaca; Marcello Delitala; Tommaso Lorenzi
Journal:  Bull Math Biol       Date:  2021-06-15       Impact factor: 1.758

10.  Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors.

Authors:  Carla Bartosch; Sara Monteiro-Reis; Renata Vieira; Armindo Pereira; Marta Rodrigues; Carmen Jerónimo; José M Lopes
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.